Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide

• Mathias Gehrmann ,

  Contributed equally to this work with: Mathias Gehrmann, Stefan Stangl, Gemma A. Foulds

  Affiliation Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

  ⨯
• Stefan Stangl ,

  Contributed equally to this work with: Mathias Gehrmann, Stefan Stangl, Gemma A. Foulds

  Affiliation Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

  ⨯
• Gemma A. Foulds ,

  Contributed equally to this work with: Mathias Gehrmann, Stefan Stangl, Gemma A. Foulds

  Affiliation John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom

  ⨯
• Rupert Oellinger,

  Affiliation Medical Department II, Translational Gastroenterological Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

  ⨯
• Stephanie Breuninger,

  Affiliation Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

  ⨯
• Roland Rad,

  Affiliation Medical Department II, Translational Gastroenterological Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

  ⨯
• Alan G. Pockley,

  Affiliation John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom

  ⨯
• Gabriele Multhoff

  * E-mail: gabriele.multhoff@lrz.tu-muenchen.de

  Affiliations Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany, Clinical Cooperation Group (CCG) ‘‘Innate Immunity in Tumor Biology’’, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany

  ⨯